2INV Stock Overview
2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
Capture your thoughts, links and company narrative
2invest AG Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€6.35|
|52 Week High||€11.30|
|52 Week Low||€6.20|
|1 Month Change||-5.93%|
|3 Month Change||-24.58%|
|1 Year Change||-42.53%|
|3 Year Change||-61.86%|
|5 Year Change||-50.93%|
|Change since IPO||-81.69%|
Recent News & Updates
|2INV||DE Biotechs||DE Market|
Return vs Industry: 2INV underperformed the German Biotechs industry which returned -7.9% over the past year.
Return vs Market: 2INV underperformed the German Market which returned -7.8% over the past year.
|2INV Average Weekly Movement||3.3%|
|Biotechs Industry Average Movement||6.4%|
|Market Average Movement||5.0%|
|10% most volatile stocks in DE Market||10.1%|
|10% least volatile stocks in DE Market||2.7%|
Stable Share Price: 2INV is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 2INV's weekly volatility (3%) has been stable over the past year.
About the Company
2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.
2invest AG Fundamentals Summary
|2INV fundamental statistics|
Is 2INV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2INV income statement (TTM)|
|Cost of Revenue||€0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-3.42|
|Net Profit Margin||-669.17%|
How did 2INV perform over the long term?See historical performance and comparison